Nrf2 and cardiovascular defense

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Howden, Reuben ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT DEFENSE; ANTIOXIDANT ENZYME; ANTIOXIDANT RESPONSE ELEMENTS; CARDIO-VASCULAR DISEASE; CELLULAR DAMAGE; CELLULAR ENVIRONMENT; ISCHEMIA-REPERFUSION INJURY; THERAPEUTIC TARGETS;

CARDIOVASCULAR SYSTEM; TRANSCRIPTION FACTORS;

DISEASES;

APOLIPOPROTEIN E; FUMARIC ACID; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR NRF2; TRITERPENOID;

AGING; ANTIOXIDANT RESPONSIVE ELEMENT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DISEASE PREDISPOSITION; HEART FAILURE; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; ANIMAL; CARDIOVASCULAR SYSTEM; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; HUMANS; HYPERTENSION; MYOCARDIAL REPERFUSION INJURY; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84877268399     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/104308     Document Type: Review

References (138)

1. Lloyd-Jones D., Adams R. J., Brown T. M., Carnethon M., Dai S., de Simone G., Ferguson T. B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P. M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M. M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V. L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N. D., Wylie-Rosett J., Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010 121 7 948 954 2-s2.0-77649091020 10.1161/CIRCULATIONAHA.109.192666
2. Harrison D., Griendling K. K., Landmesser U., Hornig B., Drexler H., Role of oxidative stress in atherosclerosis. The American Journal of Cardiology 2003 91 3, supplement 7 11 2-s2.0-0037421492 10.1016/S0002-9149(02)03144-2 (Pubitemid 36351457)
3. Park J. G., Oh G. T., The role of peroxidases in the pathogenesis of atherosclerosis. BMB Reports 2011 44 8 497 505 10.5483/BMBRep.2011.44.8.497
4. Harrison D. G., Gongora M. C., Guzik T. J., Widder J., Oxidative stress and hypertension. Journal of the American Society of Hypertension 2007 1 1 30 44 2-s2.0-34247877763 10.1016/j.jash.2006.11.006 (Pubitemid 46696606)
5. Sawyer D. B., Oxidative stress in heart failure: what are we missing? The American Journal of the Medical Sciences 2011 342 2 120 124 2-s2.0-79961021871 10.1097/MAJ.0b013e3182249fcd
6. Zweier J. L., Kuppusamy P., Lutty G. A., Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proceedings of the National Academy of Sciences of the United States of America 1988 85 11 4046 4050 2-s2.0-0000104045
7. Zweier J. L., Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. The Journal of Biological Chemistry 1988 263 3 1353 1357 2-s2.0-0023867107 (Pubitemid 18039938)
8. Afanas'ev I., ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxidative Medicine and Cellular Longevity 2011 2011 13 10.1155/2011/293769 293769
9. Sorg O., Oxidative stress: a theoretical model or a biological reality? Comptes Rendus 2004 327 7 649 662 2-s2.0-3343017533 10.1016/j.crvi.2004.05.007 (Pubitemid 38992409)
10. Berger M. M., Can oxidative damage be treated nutritionally? Clinical Nutrition 2005 24 2 172 183 2-s2.0-15344350180 10.1016/j.clnu.2004.10.003 (Pubitemid 40392800)
11. Fearon I. M., Faux S. P., Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. Journal of Molecular and Cellular Cardiology 2009 47 3 372 381 2-s2.0-67650735222 10.1016/j.yjmcc.2009.05.013
12. Janssen Y. M. W., Van Houten B., Borm P. J. A., Mossman B. T., Cell and tissue responses to oxidative damage. Laboratory Investigation 1993 69 3 261 274 2-s2.0-0027661830 (Pubitemid 23315710)
13. Hybertson B. M., Gao B., Bose S. K., McCord J. M., Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine 2011 32 4-6 234 246 10.1016/j.mam.2011.10.006
14. Madamanchi N. R., Vendrov A., Runge M. S., Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 29 38 2-s2.0-11144225245 10.1161/01.ATV.0000150649.39934.13 (Pubitemid 40054251)
15. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
16. Asakura T., Karino T., Flow patterns and spatial distributions of atherosclerotic lesions in human coronary arteries. Circulation Research 1990 66 4 1045 1066 2-s2.0-0025247921 (Pubitemid 20126435)
17. Gibson C. M., Diaz L., Kandarpa K., Sacks F. M., Pasternak R. C., Sandor T., Feldman C., Stone P. H., Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arteriosclerosis and Thrombosis 1993 13 2 310 315 2-s2.0-0027404382 (Pubitemid 23056805)
18. Ku D. N., Giddens D. P., Zarins C. K., Glagov S., Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low and oscillating shear stress. Arteriosclerosis 1985 5 3 293 302 2-s2.0-0021966255 (Pubitemid 15098005)
19. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L. J., Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006 15 4 265 279 2-s2.0-33750445289 10.1016/j.niox.2006.03.011 (Pubitemid 44649284)
20. Harrison D. G., Widder J., Grumbach I., Chen W., Weber M., Searles C., Endothelial mechanotransduction, nitric oxide and vascular inflammation. Journal of Internal Medicine 2006 259 4 351 363 2-s2.0-33644913371 10.1111/j.1365-2796. 2006.01621.x (Pubitemid 43384226)
21. Hosoya T., Maruyama A., Kang M. I., Kawatani Y., Shibata T., Uchida K., Itoh K., Yamamoto M., Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. The Journal of Biological Chemistry 2005 280 29 27244 27250 2-s2.0-22844450096 10.1074/jbc.M502551200 (Pubitemid 41040764)
22. Nigro P., Abe J. I., Berk B. C., Flow shear stress and atherosclerosis: a matter of site specificity. Antioxidants & Redox Signaling 2011 15 5 1405 1414 2-s2.0-79960815697 10.1089/ars.2010.3679
23. Bailey-Downs L. C., Mitschelen M., Sosnowska D., Toth P., Pinto J. T., Ballabh P., Valcarcel-Ares M. N., Farley J., Koller A., Henthorn J. C., Bass C., Sonntag W. E., Ungvari Z., Csiszar A., Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. The Journals of Gerontology A 2012 67 4 313 329
24. Dai G., Vaughn S., Zhang Y., Wang E. T., Garcia-Cardena G., Gimbrone M. A., Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circulation Research 2007 101 7 723 733 2-s2.0-34848858001 10.1161/CIRCRESAHA.107.152942 (Pubitemid 47494103)
25. Hosoya T., Maruyama A., Kang M.-I., Kawatani Y., Shibata T., Uchida K., Itoh K., Yamamoto M., Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. The Journal of Biological Chemistry 2005 280 29 27244 27250 2-s2.0-22844450096 10.1074/jbc.M502551200 (Pubitemid 41040764)
26. Jyrkkänen H.-K., Kansanen E., Inkala M., Kivela A. M., Hurttila H., Heinonen S. E., Goldsteins G., Jauhiainen S., Tiainen S., Makkonen H., Oskolkova O., Afonyushkin T., Koistinaho J., Yamamoto M., Bochkov V. N., Ylä-Herttuala S., Levonen A. L., Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo. Circulation Research 2008 103 1 e1 e9 2-s2.0-48049102141 10.1161/CIRCRESAHA.108.176883
27. Ungvari Z., Bagi Z., Feher A., Recchia F. A., Sonntag W. E., Pearson K., de Cabo R., Csiszar A., Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. American Journal of Physiology 2010 299 1 H18 H24 2-s2.0-77953741269 10.1152/ajpheart.00260.2010
28. Ungvari Z., Bailey-Downs L., Gautam T., Jimenez R., Losonczy G., Zhang C., Ballabh P., Recchia F. A., Wilkerson D. C., Sonntag W. E., Pearson K., de Cabo R., Csiszar A., Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. American Journal of Physiology 2011 300 4 H1133 H1140 10.1152/ajpheart.00402.2010
29. Zakkar M., Van der Heiden K., Luong L. A., Chaudhury H., Cuhlmann S., Hamdulay S. S., Krams R., Edirisinghe I., Rahman I., Carlsen H., Haskard D. O., Mason J. C., Evans P. C., Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 11 1851 1857 2-s2.0-73949142348 10.1161/ATVBAHA.109.193375
30. Zhu H., Jia Z., Zhang L., Yamamoto M., Misra H. P., Trush M. A., Li Y., Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress. Experimental Biology and Medicine 2008 233 4 463 474 2-s2.0-41549129055 10.3181/0711-RM-304 (Pubitemid 351469303)
31. Collins A. R., Gupte A. A., Ji R., Ramirez M. R., Minze L. J., Liu J. Z., Arredondo M., Ren Y., Deng T., Wang J., Lyon C. J., Hsueh W. A., Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 12 2839 2846 10.1161/ATVBAHA.112.300345
32. Ruotsalainen A. K., Inkala M., Partanen M. E., Lappalainen J. P., Kansanen E., Makinen P. I., Heinonen S. E., Laitinen H. M., Heikkila J., Vatanen T., Horkko S., Yamamoto M., Yla-Herttuala S., Jauhiainen M., Levonen A. L., The absence of macrophage Nrf2 promotes early atherogenesis. Cardiovascular Research 2013 10.1093/cvr/cvt008
33. Ishikawa K., Maruyama Y., Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. Journal of Atherosclerosis and Thrombosis 2001 8 3 63 70 2-s2.0-0035750333
34. Ishikawa K., Sugawara D., Wang X. P., Suzuki K., Itabe H., Maruyama Y., Lusis A. J., Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circulation Research 2001 88 5 506 512 2-s2.0-0035896220 10.1161/01.RES.88.5.506 (Pubitemid 32240914)
35. Orozco L. D., Kapturczak M. H., Barajas B., Wang X., Weinstein M. M., Wong J., Deshane J., Bolisetty S., Shaposhnik Z., Shih D. M., Agarwal A., Lusis A. J., Araujo J. A., Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circulation Research 2007 100 12 1703 1711 2-s2.0-34250831495 10.1161/CIRCRESAHA.107.151720 (Pubitemid 46987862)
36. Juan S. H., Lee T. S., Tseng K. W., Liou J. Y., Shyue S. K., Wu K. K., Chau L. Y., Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001 104 13 1519 1525 2-s2.0-0035949615 (Pubitemid 32917345)
37. Yet S. F., Layne M. D., Liu X., Chen Y. H., Ith B., Sibinga N. E., Perrella M. A., Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. The FASEB Journal 2003 17 12 1759 1761 2-s2.0-0141706806
38. Zhang S. H., Reddick R. L., Piedrahita J. A., Maeda N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992 258 5081 468 471 2-s2.0-0026592806
39. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992 71 2 343 353 2-s2.0-0026725757 10.1016/0092-8674(92)90362-G
40. Duckers H. J., Boehm M., True A. L., Yet S. F., San H., Park J. L., Clinton Webb R., Lee M. E., Nabel G. J., Nabel E. G., Heme oxygenase-1 protects against vascular constriction and proliferation. Nature Medicine 2001 7 6 693 698 2-s2.0-0034959256 10.1038/89068 (Pubitemid 32588025)
41. Tulis D. A., Durante W., Peyton K. J., Evans A. J., Schafer A. I., Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 2001 155 1 113 122 2-s2.0-0035112603 10.1016/S0021-9150(00)00552-9 (Pubitemid 32167130)
42. Han Z., Varadharaj S., Giedt R. J., Zweier J. L., Szeto H. H., Alevriadou B. R., Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cellss. The Journal of Pharmacology and Experimental Therapeutics 2009 329 1 94 101 2-s2.0-63849133179 10.1124/jpet.108.145557
43. Boyle J. J., Johns M., Lo J., Chiodini A., Ambrose N., Evans P. C., Mason J. C., Haskard D. O., Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 11 2685 2691 10.1161/ATVBAHA.111.225813
44. Libby P., Okamoto Y., Rocha V. Z., Folco E., Inflammation in atherosclerosis: transition from theory to practice. Circulation Journal 2010 74 2 213 220 2-s2.0-75749148425 10.1253/circj.CJ-09-0706
45. Morrison J. A., Jacobsen D. W., Sprecher D. L., Robinson K., Khoury P., Daniels S. R., Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation 1999 100 22 2244 2247 2-s2.0-0032736062
46. Buijsse B., Lee D. H., Steffen L., Erickson R. R., Luepker R. V., Jacobs D. R. Jr, Holtzman J. L., Low serum glutathione peroxidase activity is associated with increased cardiovascular mortality in individuals with low HDLc's. PLoS ONE 2012 7 6 e38901 10.1371/journal.pone.0038901
47. Singh A., Rangasamy T., Thimmulappa R. K., Lee H., Osburn W. O., Brigelius-Flohe R., Kensler T. W., Yamamoto M., Biswal S., Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. American Journal of Respiratory Cell and Molecular Biology 2006 35 6 639 650 10.1165/rcmb.2005-0325OC (Pubitemid 44901853)
48. Konstantino Y., Nguyen T. T., Wolk R., Aiello R. J., Terra S. G., Fryburg D. A., Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease. Biomarkers 2009 14 2 118 129 2-s2.0-66149133714 10.1080/13547500902765140
49. Gough P. J., Gomez I. G., Wille P. T., Raines E. W., Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. The Journal of Clinical Investigation 2006 116 1 59 69 2-s2.0-31044446194 10.1172/JCI25074 (Pubitemid 43121791)
50. Wu M. L., Ho Y. C., Yet S. F., A central role of heme oxygenase-1 in cardiovascular protection. Antioxidants & Redox Signaling 2011 15 7 1835 1846 10.1089/ars.2010.3726
51. Zakkar M., Van der Heiden K., Luong L. A., Chaudhury H., Cuhlmann S., Hamdulay S. S., Krams R., Edirisinghe I., Rahman I., Carlsen H., Haskard D. O., Mason J. C., Evans P. C., Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 11 1851 1857 2-s2.0-73949142348 10.1161/ATVBAHA.109.193375
52. Thimmulappa R. K., Mai K. H., Srisuma S., Kensler T. W., Yamamoto M., Biswal S., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research 2002 62 18 5196 5203 2-s2.0-0037106099 (Pubitemid 35033454)
53. Hu R., Xu C., Shen G., Jain M. R., Khor T. O., Gopalkrishnan A., Lin W., Reddy B., Chan J. Y., Kong A. N. T., Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Letters 2006 243 2 170 192 2-s2.0-33746889956 10.1016/j.canlet.2005.11.050 (Pubitemid 44485856)
54. Riedl M. A., Saxon A., Diaz-Sanchez D., Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clinical Immunology 2009 130 3 244 251 2-s2.0-59249103720 10.1016/j.clim.2008.10.007
55. Cho H. Y., Imani F., Miller-DeGraff L., Walters D., Melendi G. A., Yamamoto M., Polack F. P., Kleeberger S. R., Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. American Journal of Respiratory and Critical Care Medicine 2009 179 2 138 150 2-s2.0-58449116694 10.1164/rccm.200804-535OC
56. Sussan T. E., Jun J., Thimmulappa R., Bedja D., Antero M., Gabrielson K. L., Polotsky V. Y., Biswal S., Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS ONE 2008 3 11 2-s2.0-56849124834 10.1371/journal.pone.0003791 e3791
57. Barajas B., Che N., Yin F., Rowshanrad A., Orozco L. D., Gong K. W., Wang X., Castellani L. W., Reue K., Lusis A. J., Araujo J. A., NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 58 66 2-s2.0-78650913866 10.1161/ATVBAHA.110. 210906
58. Lynch J., Kaplan G. A., Salonen R., Salonen J. T., Socioeconomic status and progression of carotid atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 3 513 519 2-s2.0-0030999860
59. Ishii T., Itoh K., Ruiz E., Leake D. S., Unoki H., Yamamoto M., Mann G. E., Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circulation Research 2004 94 5 609 616 2-s2.0-1642396537 10.1161/01.RES. 0000119171.44657.45 (Pubitemid 38387743)
60. Ishikawa K., Sugawara D., Goto J., Watanabe Y., Kawamura K., Shiomi M., Itabe H., Maruyama Y., Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001 104 15 1831 1836 2-s2.0-0035834084 (Pubitemid 32963350)
61. Celletti F. L., Waugh J. M., Amabile P. G., Brendolan A., Hilfiker P. R., Dake M. D., Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nature Medicine 2001 7 4 425 429 2-s2.0-0035047885 10.1038/86490 (Pubitemid 32298544)
62. Lucerna M., Zernecke A., de Nooijer R., de Jager S. C., Bot I., Van der Lans C., Kholova I., Liehn E. A., Van Berkel T. J. C., Yla-Herttuala S., Weber C., Biessen E. A. L., Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 2007 109 1 122 129 2-s2.0-33846002305 10.1182/blood-2006-07-031773 (Pubitemid 46053052)
63. Afonyushkin T., Oskolkova O. V., Philippova M., Resink T. J., Erne P., Binder B. R., Bochkov V. N., Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 5 1007 1013 2-s2.0-77951479702 10.1161/ATVBAHA.110.204354
64. Chen X. L., Varner S. E., Rao A. S., Grey J. Y., Thomas S., Cook C. K., Wasserman M. A., Medford R. M., Jaiswal A. K., Kunsch C., Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. The Journal of Biological Chemistry 2003 278 2 703 711 2-s2.0-0037428445 10.1074/jbc.M203161200 (Pubitemid 36790739)
65. Chapple S. J., Siow R. C., Mann G. E., Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. The International Journal of Biochemistry & Cell Biology 2012 44 8 1315 1320 10.1016/j.biocel.2012.04.021
66. Freigang S., Ampenberger F., Spohn G., Heer S., Shamshiev A. T., Kisielow J., Hersberger M., Yamamoto M., Bachmann M. F., Kopf M., Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. European Journal of Immunology 2011 41 7 2040 2051 2-s2.0-79959732295 10.1002/eji.201041316
67. de Groot H., Rauen U., Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplantation Proceedings 2007 39 2 481 484 2-s2.0-33847728252 10.1016/j.transproceed.2006.12.012 (Pubitemid 46386215)
68. Cao Z., Zhu H., Zhang L., Zhao X., Zweier J. L., Li Y., Antioxidants and phase 2 enzymes in cardiomyocytes: chemical inducibility and chemoprotection against oxidant and simulated ischemia-reperfusion injury. Experimental Biology and Medicine 2006 231 8 1353 1364 2-s2.0-33748288140 (Pubitemid 44330571)
69. Gurusamy N., Malik G., Gorbunov N. V., Das D. K., Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radical Biology & Medicine 2007 43 3 397 407 2-s2.0-34250887598 10.1016/j.freeradbiomed.2007.04.025 (Pubitemid 46977631)
70. Calvert J. W., Jha S., Gundewar S., Elrod J. W., Ramachandran A., Pattillo C. B., Kevil C. G., Lefer D. J., Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circulation Research 2009 105 4 365 374 2-s2.0-70349233030 10.1161/CIRCRESAHA.109.199919
71. Zhang Y., Sano M., Shinmura K., Tamaki K., Katsumata Y., Matsuhashi T., Morizane S., Ito H., Hishiki T., Endo J., Zhou H., Yuasa S., Kaneda R., Suematsu M., Fukuda K., 4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. Journal of Molecular and Cellular Cardiology 2010 49 4 576 586 2-s2.0-77956101963 10.1016/j.yjmcc.2010.05.011
72. Grossman E., Does increased oxidative stress cause hypertension? Diabetes care 2008 31 supplement 2 S185 S189 2-s2.0-41149152820
73. de Champlain J., Wu R., Girouard H., Karas M., Midaoui A. E. L., Laplante M. A., Wu L., Oxidative stress in hypertension. Clinical and Experimental Hypertension 2004 26 7-8 593 601 2-s2.0-12344313062 10.1081/CEH-200031904 (Pubitemid 40129747)
74. Delles C., Miller W. H., Dominiczak A. F., Targeting reactive oxygen species in hypertension. Antioxidants & Redox Signaling 2008 10 6 1061 1077 2-s2.0-41349083103 10.1089/ars.2007.2008 (Pubitemid 351451714)
75. Mehta P. K., Griendling K. K., Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American Journal of Physiology 2007 292 1 C82 C97 2-s2.0-33846362954 10.1152/ajpcell. 00287.2006 (Pubitemid 46127306)
76. Brandes R. P., Weissmann N., Schröder K., NADPH oxidases in cardiovascular disease. Free Radical Biology & Medicine 2010 49 5 687 706 2-s2.0-77955096004 10.1016/j.freeradbiomed.2010.04.030
77. Jung O., Schreiber J. G., Geiger H., Pedrazzini T., Busse R., Brandes R. P., gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 2004 109 14 1795 1801 2-s2.0-3342983728 10.1161/01.CIR.0000124223.00113.A4 (Pubitemid 38500684)
78. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., Takai S., Yamanishi K., Miyazaki M., Matsubara H., Yabe-Nishimura C., Nox1 is involved in angiotensin II-mediated hypertension. Circulation 2005 112 17 2677 2685 2-s2.0-27444441677 10.1161/CIRCULATIONAHA.105.573709 (Pubitemid 41532605)
79. Malec V., Gottschald O. R., Li S., Rose F., Seeger W., Hänze J., HIF-1 α signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radical Biology & Medicine 2010 48 12 1626 1635 2-s2.0-77952671413 10.1016/j.freeradbiomed.2010.03.008
80. Murdoch C. E., Alom-Ruiz S. P., Wang M., Zhang M., Walker S., Yu B., Brewer A., Shah A. M., Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Research in Cardiology 2011 106 4 527 538 2-s2.0-79959704368 10.1007/s00395-011-0179-7
81. Chen T. M., Li J., Liu L., Fan L., Li X. Y., Wang Y. T., Abraham N. G., Cao J., Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction. International Journal of Molecular Sciences 2013 14 2 2684 2706 10.3390/ijms14022684
82. Sacerdoti D., Escalante B., Abraham N. G., McGiff J. C., Levere R. D., Schwartzman M. L., Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989 243 4889 388 390 2-s2.0-0024587145 (Pubitemid 19047515)
83. Escalante B., Sacerdoti D., Davidian M. M., Laniado-Schwartzman M., McGiff J. C., Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 1991 17 6, part 1 776 779 2-s2.0-0026042574
84. Ryter S. W., Otterbein L. E., Morse D., Choi A. M. K., Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Molecular and Cellular Biochemistry 2002 234-235 1-2 249 263 2-s2.0-4243550127 10.1023/A:1015957026924 (Pubitemid 34777864)
85. Sacerdoti D., Mania D., Pesce P., Gaiani S., Gatta A., Bolognesi M., Role of HO/CO in the control of peripheral circulation in humans. International Journal of Hypertension 2012 2012 4 236180 10.1155/2012/236180
86. Morita T., Kourembanas S., Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. The Journal of Clinical Investigation 1995 96 6 2676 2682 2-s2.0-0028838293
87. Ndisang J. F., Zhao W., Wang R., Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 2002 40 3 315 321 2-s2.0-0036711791 10.1161/01.HYP.0000028488.71068.16 (Pubitemid 35006717)
88. Levere R. D., Martasek P., Escalante B., Schwartzman M. L., Abraham N. G., Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. The Journal of Clinical Investigation 1990 86 1 213 219 2-s2.0-0025332748 (Pubitemid 20226994)
89. Martasek P., Schwartzman M. L., Goodman A. I., Solangi K. B., Levere R. D., Abraham N. G., Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. Journal of the American Society of Nephrology 1991 2 6 1078 1084 2-s2.0-0026303693
90. Chen Y. H., Yet S. F., Perrella M. A., Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Experimental Biology and Medicine 2003 228 5 447 453 2-s2.0-0038545240 (Pubitemid 37203658)
91. Li J., Zhang C., Xing Y., Janicki J. S., Yamamoto M., Wang X. L., Tang D. Q., Cui T., Up-regulation of p27kip1 contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy. Cardiovascular Research 2011 90 2 315 324 2-s2.0-79955418633 10.1093/cvr/cvr010
92. Gomez-Guzman M., Jimenez R., Sanchez M., Zarzuelo M. J., Galindo P., Quintela A. M., Lopez-Sepulveda R., Romero M., Tamargo J., Vargas F., Perez-Vizcaino F., Duarte J., Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radical Biology & Medicine 2012 52 1 70 79 10.1016/j.freeradbiomed.2011.09.015
93. Bolli R., Zhu W. X, Hartley C. J., Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea. Circulation 1987 76 2 458 468 2-s2.0-0023278986 (Pubitemid 17124750)
94. Beresewicz A., Horackova M., Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms. Journal of Molecular and Cellular Cardiology 1991 23 8 899 918 2-s2.0-0025822581 10.1016/0022-2828(91)90133-7
95. Chesley A., Lundberg M. S., Asai T., Xiao R. P., Ohtani S., Lakatta E. G., Crow M. T., The β 2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′ -kinase. Circulation Research 2000 87 12 1172 1179 2-s2.0-0034623819
96. Wiesel P., Patel A. P., Carvajal I. M., Wang Z. Y., Pellacani A., Maemura K., DiFonzo N., Rennke H. G., Layne M. D., Yet S. F., Lee M. E., Perrella M. A., Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circulation Research 2001 88 10 1088 1094 2-s2.0-0035947746 (Pubitemid 34137123)
97. Hu C.-M., Chen Y.-H., Chiang M.-T., Chau L.-Y., Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 2004 110 3 309 316 2-s2.0-3242661655 10.1161/01.CIR.0000135475.35758.23 (Pubitemid 38955500)
98. Lu Z., Xu X., Hu X., Zhu G., Zhang P., Van Deel E. D., French J. P., Fassett J. T., Oury T. D., Bache R. J., Chen Y., Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension 2008 51 1 19 25 2-s2.0-37349041037 10.1161/HYPERTENSIONAHA.107.098186 (Pubitemid 350307094)
99. Matsushima S., Kinugawa S., Ide T., Matsusaka H., Inoue N., Ohta Y., Yokota T., Sunagawa K., Tsutsui H., Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. American Journal of Physiology 2006 291 5 H2237 H2245 2-s2.0-33751274535 10.1152/ajpheart.00427.2006 (Pubitemid 44794216)
100. Li J., Ichikawa T., Villacorta L., Janicki J. S., Brower G. L., Yamamoto M., Cui T., Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 11 1843 1850 2-s2.0-70350115341 10.1161/ATVBAHA.109.189480
101. Brewer A. C., Murray T. V. A., Arno M., Zhang M., Anilkumar N. P., Mann G. E., Shah A. M., Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radical Biology & Medicine 2011 51 1 205 215 2-s2.0-79957954491 10.1016/j.freeradbiomed.2011.04.022
102. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M. D., Sadoshima J., NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proceedings of the National Academy of Sciences of the United States of America 2010 107 35 15565 15570 2-s2.0-77957272433 10.1073/pnas.1002178107
103. Ashrafian H., Czibik G., Bellahcene M., Aksentijevic D., Smith A. C., Mitchell S. J., Dodd M. S., Kirwan J., Byrne J. J., Ludwig C., Isackson H., Yavari A., Stottrup N. B., Contractor H., Cahill T. J., Sahgal N., Ball D. R., Birkler R. I., Hargreaves I., Tennant D. A., Land J., Lygate C. A., Johannsen M., Kharbanda R. K., Neubauer S., Redwood C., de Cabo R., Ahmet I., Talan M., Gunther U. L., Robinson A. J., Viant M. R., Pollard P. J., Tyler D. J., Watkins H., Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metabolism 2012 15 3 361 371 10.1016/j.cmet.2012.01.017
104. Ichikawa T., Li J., Meyer C. J., Janicki J. S., Hannink M., Cui T., Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes. PLoS ONE 2009 4 12 e8391 2-s2.0-77949526652
105. Xing Y., Niu T., Wang W., Li J., Li S., Janicki J. S., Ruiz S., Meyer C. J., Wang X. L., Tang D., Zhao Y., Cui T., Triterpenoid dihydro-CDDO- trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS ONE 2012 7 9 e44899 10.1371/journal.pone.0044899
106. Sussan T. E., Rangasamy T., Blake D. J., Malhotra D., El-Haddad H., Bedja D., Yates M. S., Kombairaju P., Yamamoto M., Liby K. T., Sporn M. B., Gabrielson K. L., Champion H. C., Tuder R. M., Kensler T. W., Biswal S., Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proceedings of the National Academy of Sciences of the United States of America 2009 106 1 250 255 2-s2.0-58549105575 10.1073/pnas.0804333106
107. Motohashi H., Yamamoto M., Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends in Molecular Medicine 2004 10 11 549 557 2-s2.0-7244253081 10.1016/j.molmed.2004.09.003 (Pubitemid 39433824)
108. Rajasekaran N. S., Connell P., Christians E. S., Yan L. J., Taylor R. P., Orosz A., Zhang X. Q., Stevenson T. J., Peshock R. M., Leopold J. A., Barry W. H., Loscalzo J., Odelberg S. J., Benjamin I. J., Human α B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 2007 130 3 427 439 2-s2.0-34547681313 10.1016/j.cell.2007.06.044 (Pubitemid 47208522)
109. Rajasekaran N. S., Varadharaj S., Khanderao G. D., Davidson C. J., Kannan S., Firpo M. A., Zweier J. L., Benjamin I. J., Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. Antioxidants & Redox Signaling 2011 14 6 957 971 2-s2.0-79951918162 10.1089/ars.2010.3587
110. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., Goldblatt C. S., Meyer C. J., Li X., Cai L., Cui T., Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011 60 2 625 633 2-s2.0-79551575483 10.2337/db10-1164
111. Papaiahgari S., Kleeberger S. R., Cho H. Y., Kalvakolanu D. V., Reddy S. P., NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells. The Journal of Biological Chemistry 2004 279 40 42302 42312 2-s2.0-4744360664 10.1074/jbc.M408275200 (Pubitemid 39313679)
112. Guyton K. Z., Gorospe M., Kensler T. W., Holbrook N. J., Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion. Cancer Research 1996 56 15 3480 3485 2-s2.0-0029945349 (Pubitemid 26251640)
113. 2: role in cell survival following oxidant injury. The Journal of Biological Chemistry 1996 271 8 4138 4142 2-s2.0-0030049439
114. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., Shiojima I., Hiroi Y., Yazaki Y., Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. The Journal of Clinical Investigation 1997 100 7 1813 1821 2-s2.0-0030886770 (Pubitemid 27431340)
115. Wang X., Martindale J. L., Liu Y., Holbrook N. J., The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochemical Journal 1998 333, part 2 291 300 2-s2.0-0032527705 (Pubitemid 28379529)
116. Peus D., Pittelkow M. R., Reactive oxygen species as mediators of UVB-induced mitogen-activated protein kinase activation in keratinocytes. Current Problems in Dermatology 2001 29 114 127 2-s2.0-0035230146
117. Ikeyama S., Kokkonen G., Shack S., Wang X. T., Holbrook N. J., Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities. The FASEB Journal 2002 16 1 114 116 2-s2.0-0036368596
118. Petrache I., Choi M. E., Otterbein L. E., Chin B. Y., Mantell L. L., Horowitz S., Choi A. M. K., Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. American Journal of Physiology 1999 277 3 L589 L595 2-s2.0-0032886918 (Pubitemid 29459679)
119. Zhang X., Shan P., Sasidhar M., Chupp G. L., Flavell R. A., Choi A. M. K., Lee P. J., Reactive oxygen species and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase mediate hyperoxia-induced cell death in lung epithelium. American Journal of Respiratory Cell and Molecular Biology 2003 28 3 305 315 2-s2.0-0037369376 10.1165/rcmb.2002-0156OC (Pubitemid 36238007)
120. Murphy L. O., Blenis J., MAPK signal specificity: the right place at the right time. Trends in Biochemical Sciences 2006 31 5 268 275 2-s2.0-33646336602 10.1016/j.jsg.2005.10.009
121. Cagnol S., Chambard J. C., ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS Journal 2010 277 1 2 21 2-s2.0-73649089980 10.1111/j.1742-4658.2009.07366.x
122. Muthusamy V. R., Kannan S., Sadhaasivam K., Gounder S. S., Davidson C. J., Boeheme C., Hoidal J. R., Wang L., Rajasekaran N. S., Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radical Biology & Medicine 2012 52 2 366 376 10.1016/j.freeradbiomed.2011.10.440
123. Suh J. H., Shenvi S. V., Dixon B. M., Liu H., Jaiswal A. K., Liu R. M., Hagen T. M., Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proceedings of the National Academy of Sciences of the United States of America 2004 101 10 3381 3386 2-s2.0-1542723493 10.1073/pnas.0400282101 (Pubitemid 38338203)
124. Ungvari Z., Bailey-Downs L., Gautam T., Sosnowska D., Wang M., Monticone R. E., Telljohann R., Pinto J. T., de Cabo R., Sonntag W. E., Lakatta E. G., Csiszar A., Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta. The Journals of Gerontology A 2011 66 8 866 875
125. Ungvari Z., Bailey-Downs L., Sosnowska D., Gautam T., Koncz P., Losonczy G., Ballabh P., de Cabo R., Sonntag W. E., Csiszar A., Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response. American Journal of Physiology 2011 301 2 H363 H372 2-s2.0-79961043903 10.1152/ajpheart.01134.2010
126. Goldberg R. J., Gore J. M., Gurwitz J. H., Coronary thrombolysis for the elderly? The Journal of the American Medical Association 1991 265 13 1720 1723 2-s2.0-0025854527 10.1001/jama.265.13.1720
127. Gounder S. S., Kannan S., Devadoss D., Miller C. J., Whitehead K. S., Odelberg S. J., Firpo M. A., Paine III R., Hoidal J. R., Abel E. D., Rajasekaran N. S., Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PLoS ONE 2012 7 9 e45697
128. Cho H. Y., Jedlicka A. E., Reddy S. P. M., Zhang L. Y., Kensler T. W., Kleeberger S. R., Linkage analysis of susceptibility to hyperoxia Nrf2 is a candidate gene. American Journal of Respiratory Cell and Molecular Biology 2002 26 1 42 51 2-s2.0-0036006792 (Pubitemid 34029819)
129. Schraufnagel D. E., Basterra J. L., Hainis K., Sznajder J. I., Lung lymphatics increase after hyperoxic injury: an ultrastructural study of casts. The American Journal of Pathology 1994 144 6 1393 1402 2-s2.0-0028222553 (Pubitemid 24172101)
130. Parrish D. A., Mitchell B. C., Henson P. M., Larsen G. L., Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia. The Journal of Clinical Investigation 1984 74 3 956 965 2-s2.0-0021148267 (Pubitemid 14031034)
131. Jones R., Zapol W. M., Reid L., Oxygen toxicity and restructuring of pulmonary arteries-a morphometric study. The response to 4 weeks' exposure to hyperoxia and return to breathing air. The American Journal of Pathology 1985 121 2 212 223 2-s2.0-0022340513 (Pubitemid 16230689)
132. Johnston C. J., Mango G. W., Finkelstein J. N., Stripp B. R., Altered pulmonary response to hyperoxia in clara cell secretory protein deficient mice. American Journal of Respiratory Cell and Molecular Biology 1997 17 2 147 155 2-s2.0-0031203261 (Pubitemid 127499013)
133. Margaretten N. C., Witschi H., Effects of hyperoxia on growth characteristics of metastatic murine tumors in the lung. Cancer Research 1988 48 10 2779 2783 2-s2.0-0023939461
134. O'Reilly M. A., Staversky R. J., Stripp B. R., Finkelstein J. N., Exposure to hyperoxia induces p53 expression in mouse lung epithelium. American Journal of Respiratory Cell and Molecular Biology 1998 18 1 43 50 2-s2.0-0031605509 (Pubitemid 128355345)
135. Crapo J. D., Morphologic changes in pulmonary oxygen toxicity. Annual Review of Physiology 1986 48 721 731 2-s2.0-0022559220 (Pubitemid 16047645)
136. Howden R., Cho H. Y., Miller-DeGraff L., Walker C., Clark J. A., Myers P. H., Rouse D. C., Kleeberger S. R., Cardiac physiologic and genetic predictors of hyperoxia-induced acute lung injury in mice. American Journal of Respiratory Cell and Molecular Biology 2012 46 4 470 478 10.1165/rcmb.2011-0204OC
137. Howden R., Liu E., Miller-DeGraff L., Keener H. L., Walker C., Clark J. A., Myers P. H., Rouse D. C., Wiltshire T., Kleeberger S. R., The genetic contribution to heart rate and heart rate variability in quiescent mice. American Journal of Physiology 2008 295 1 H59 H68 2-s2.0-49849089701 10.1152/ajpheart.00941.2007
138. Parekh A. K., Barton M. B., The challenge of multiple comorbidity for the US health care system. The Journal of the American Medical Association 2010 303 13 1303 1304 2-s2.0-77950498540 10.1001/jama.2010.381